Immunicum AB (publ) Announces that its CFO, Michaela Gertz, Will Leave the Company this Summer
Keep reading
Immunicum AB (publ) Presents Updated Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer at ASCO-SITC Clinical Immuno-Oncology Symposium
